These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 31536952

  • 1. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G, Singh S, Monga V, Thanikachalam PV, Chawla P.
    Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ, Alam O, Alam MJ, Shaquiquzzaman M, Alam MM, Naidu VGM.
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [Abstract] [Full Text] [Related]

  • 3. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S, Alam MS, Hamid H, Shahar Yar M, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai K.
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [Abstract] [Full Text] [Related]

  • 4. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 5. Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.
    Chahal S, Rani P, Shweta, Goel KK, Joshi G, Singh R, Kumar P, Singh D, Sindhu J.
    Bioorg Chem; 2024 Jun; 147():107363. PubMed ID: 38657527
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A, Bhatia R, Chawla P.
    Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
    [Abstract] [Full Text] [Related]

  • 7. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S, Alam MS, Hamid H, Yar MS, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai KK.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3034-42. PubMed ID: 24890090
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ, Alam O, Alam MJ, Hassan MQ, Siddiqui N, Naidu VGM, Alam MI.
    Bioorg Chem; 2018 Feb 15; 76():98-112. PubMed ID: 29169079
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
    Somakala K, Tariq S, Amir M.
    Bioorg Chem; 2019 Jun 15; 87():550-559. PubMed ID: 30928877
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-α inhibitory activity.
    Abd El-Karim SS, Mohamed HS, Abdelhameed MF, El-Galil E Amr A, Almehizia AA, Nossier ES.
    Bioorg Chem; 2021 Jun 15; 111():104827. PubMed ID: 33798845
    [Abstract] [Full Text] [Related]

  • 12. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
    Abd El Razik HA, Badr MH, Atta AH, Mouneir SM, Abu-Serie MM.
    Arch Pharm (Weinheim); 2017 May 15; 350(5):. PubMed ID: 28418202
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
    Bandgar BP, Adsul LK, Chavan HV, Jalde SS, Shringare SN, Shaikh R, Meshram RJ, Gacche RN, Masand V.
    Bioorg Med Chem Lett; 2012 Sep 15; 22(18):5839-44. PubMed ID: 22901385
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms.
    Liu K, Zhao X, Qi X, Hou DL, Li HB, Gu YH, Xu QL.
    Eur J Med Chem; 2021 Jun 05; 218():113388. PubMed ID: 33784603
    [Abstract] [Full Text] [Related]

  • 15. Thiazolidine-2,4-diones: progress towards multifarious applications.
    Jain VS, Vora DK, Ramaa CS.
    Bioorg Med Chem; 2013 Apr 01; 21(7):1599-620. PubMed ID: 23419324
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.
    Hu Y, Wang B, Yang J, Liu T, Sun J, Wang X.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):15-30. PubMed ID: 30362362
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of new curcumin derivatives as influential antidiabetic α-glucosidase and α-amylase inhibitors with anti-oxidant activity.
    Tavaf Z, Dangolani SK, Yousefi R, Panahi F, Shahsavani MB, Khalafi-Nezhad A.
    Carbohydr Res; 2020 Aug 01; 494():108069. PubMed ID: 32563890
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, structural characterizations, in vitro biological evaluation and computational investigations of pyrazole derivatives as potential antidiabetic and antioxidant agents.
    Mortada S, Karrouchi K, Hamza EH, Oulmidi A, Bhat MA, Mamad H, Aalilou Y, Radi S, Ansar M, Masrar A, Faouzi MEA.
    Sci Rep; 2024 Jan 15; 14(1):1312. PubMed ID: 38225280
    [Abstract] [Full Text] [Related]

  • 19. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations.
    Thangarasu P, Manikandan A, Thamaraiselvi S.
    Bioorg Chem; 2019 May 15; 86():410-419. PubMed ID: 30769266
    [Abstract] [Full Text] [Related]

  • 20. Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.
    Elkamhawy A, Kim NY, Hassan AHE, Park JE, Paik S, Yang JE, Oh KS, Lee BH, Lee MY, Shin KJ, Pae AN, Lee KT, Roh EJ.
    Eur J Med Chem; 2020 Feb 15; 188():111955. PubMed ID: 31893550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.